BIM-mediated apoptosis and oncogene addiction.
Division of Oncology, Departments of Medicine and Pathology, Stanford University, Stanford, CA 94305, USA.
Yulin
Y
Li
Division of Oncology, Departments of Medicine and Pathology, Stanford University, Stanford, CA 94305, USA.
Anja
A
Deutzmann
Division of Oncology, Departments of Medicine and Pathology, Stanford University, Stanford, CA 94305, USA.
Dean W
DW
Felsher
D000818:Animals; D017209:Apoptosis; D000072224:Bcl-2-Like Protein 11 / Q000235:genetics* / Q000378:metabolism; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D000074723:Oncogene Addiction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D015398:Signal Transduction
D000072224:Bcl-2-Like Protein 11
BIM; apoptosis; oncogene addiction; oncogene inactivation; targeted therapy
Oncotarget. 2016 May 10;7(19):26926-34
27095570
Science. 1999 Nov 26;286(5445):1735-8
10576740
Dev Cell. 2007 Feb;12 (2):221-34
17276340
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6164-9
15079075
Adv Pharmacol. 2012;65:519-42
22959036
Oncotarget. 2015 Sep 15;6(27):23058-134
26405162
Science. 2002 Jul 5;297(5578):63-4
12098689